Arterial hypertension assessment in a population with chronic myeloid leukemia

Treatment of chronic myeloid leukaemia (CML) is based on tyrosine kinase inhibitors (TKI), whose introduction in 2001 improved the survival rate after 5 years from 40 to 90%. The longevity increase has been accompanied by a higher incidence of cardiovascular events (CVE) that can be explained due to...

Descripción completa

Detalles Bibliográficos
Autores principales: Roa-Chamorro, Ricardo, Jaén-Águila, Fernando, Puerta-Puerta, José Manuel, Torres-Quintero, Lucía, González-Bustos, Pablo, Mediavilla-García, Juan Diego
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289992/
https://www.ncbi.nlm.nih.gov/pubmed/34282224
http://dx.doi.org/10.1038/s41598-021-94127-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289992/
https://www.ncbi.nlm.nih.gov/pubmed/34282224
http://dx.doi.org/10.1038/s41598-021-94127-2

Ejemplares similares